US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

F/m Emerald Life Sciences Innovation ETF

42.61

+0.93212.24%

Post-market: 42.680.0729+0.17%16:10 EDT

Volume:561

Turnover:23.88K

Market Cap:118.32M

PE:- -

High:42.68

Open:42.52

Low:42.52

Close:41.68

52wk High:48.78

52wk Low:29.44

Shares:2.78M

Float Shares:2.78M

Volume Ratio:0.36

T/O Rate:0.02%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Protagonist announces Takeda received U.S. FDA approval for MIMRYLO

Does Guardant Health’s (GH) Patent Appeal Reshape Its Competitive Moat More Than Its Royalty Bill?

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Spyre Therapeutics (SYRE)

Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO

Takeda receives FDA approval of NDA for Mimrylo

Labcorp to Present at Morgan Stanley Healthcare Conference

Roche receives FDA approval for companion diagnostic tests for Ziihera

Top Midday Decliners

MT Newswires Live

Revolution Medicines prices Rasonque at $39,800 for 30-day supply

Revolution Medicines announces FDA approval of Rasonque in adults

Spyre Therapeutics falls -13.2%

Spyre Therapeutics Down over 12%, on Pace for Largest Percent Decrease Since June 2024

U.S. Stocks on the MOVE-Semtech, Donaldson, Meta

Spyre Therapeutics (SYRE) Gets a Buy from LifeSci Capital

Analysts Offer Insights on Healthcare Companies: Solventum Corporation (SOLV), Argenx Se (ARGX) and Spyre Therapeutics (SYRE)

Spyre Therapeutics Reports Phase 2 Skyway RA Data for Spy072 Shows Statistically Significant Benefit vs Placebo

Spyre Therapeutics Shares Down 12.4% Premarket After Co's Experimental Drug Fails to Meet Threshold for Monotherapy Development in Rheumatoid Arthritis

THOMSON REUTERS

Circio and Full Circles join forces on non-viral in vivo cell therapy platform

Spyre Therapeutics Inc : Btig Cuts Target Price to $121 from $132

THOMSON REUTERS

Stocks to Watch: Intuit, Spyre Therapeutics, Zoom Communications, nCino

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/LFSC/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LFSC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LFSC\",,,,,undefined,":{"symbol":"LFSC","market":"US","secType":"STK","nameCN":"F/m Emerald Life Sciences Innovation ETF","latestPrice":42.6071,"timestamp":1791576000000,"preClose":41.675,"halted":0,"volume":561,"hourTrading":{"tag":"盘后","latestPrice":42.68,"preClose":42.6071,"latestTime":"16:10 EDT","volume":1,"amount":42.6071,"timestamp":1791576604081,"change":0.0729,"changeRate":0.001711,"amplitude":0},"delay":0,"changeRate":0.022365926814637206,"floatShares":2777035,"shares":2777035,"eps":0,"marketStatus":"Market Closed","change":0.9321,"latestTime":"10-09 16:00:00 EDT","open":42.515,"high":42.68,"low":42.515,"amount":23883,"amplitude":0.003959,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":41.675,"sharesOutstanding":2657035,"nav":41.68,"aum":115746818.8,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":42.68,"preClose":42.6071,"latestTime":"16:10 EDT","volume":1,"amount":42.6071,"timestamp":1791576604081,"change":0.0729,"changeRate":0.001711,"amplitude":0},"volumeRatio":0.35855808645794174},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LFSC\",,,,,undefined,":{"symbol":"LFSC","floatShares":2777035,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.35855808645794174,"shares":2777035,"dividePrice":0,"high":42.68,"amplitude":0.003959,"preClose":41.675,"low":42.515,"week52Low":29.4441,"pbRate":"--","week52High":48.78,"institutionHeld":0,"latestPrice":42.6071,"eps":0,"divideRate":0,"volume":561,"delay":0,"ttmEps":0,"open":42.515,"prevYearClose":36.6147,"prevWeekClose":43.401,"prevMonthClose":44.5697,"prevQuarterClose":44.5697,"fiveDayClose":43.401,"twentyDayClose":45.3275,"sixtyDayClose":44.9054},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LFSC\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LFSC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LFSC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LFSC\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663588047","title":"Protagonist announces Takeda received U.S. FDA approval for MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663588047","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663588047?lang=en_us&edition=fundamental","pubTime":"2026-08-31 04:35","pubTimestamp":1788122107,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics (PTGX) announced that Takeda (TAK) received U.S. Food and Drug Administration, FDA, approval for MIMRYLO, a subcutaneously...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","MRNY","BK4585","IYH","PSCH","LABU","BK4588","BK4139","BBP","XLVX","IEIH","RSPH","BK4007","TBXU","MEDI","GDOC","FRTY","NVIB","IBB","TECB","PTGX","PINK","LFSC","MRNX","BMED","GNMX","SYNB","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663044590","title":"Does Guardant Health’s (GH) Patent Appeal Reshape Its Competitive Moat More Than Its Royalty Bill?","url":"https://stock-news.laohu8.com/highlight/detail?id=2663044590","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663044590?lang=en_us&edition=fundamental","pubTime":"2026-08-30 19:19","pubTimestamp":1788088793,"startTime":"0","endTime":"0","summary":"In August 2026, Guardant Health said it would appeal a US District Court of Delaware final judgment in a patent dispute with TwinStrand Biosciences and the University of Washington, with execution of the judgment and collection of potential royalties paused during the appeal.\nThe court’s royalty order applies mainly to older Guardant tests, while Guardant reports that upgraded versions of key products such as Shield and Reveal, along with validated design changes to Guardant360, fall outside...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/does-guardant-healths-gh-patent-appeal-reshape-its-competiti","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/does-guardant-healths-gh-patent-appeal-reshape-its-competiti","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0320765992.SGD","BK4196","BK4588","GNMX","HELX","BK4585","LFSC","LU0889565916.HKD","PTH","FFOX","LU0109394709.USD","GDOC","GNOM","BK4551","EKG","BK4535","GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663464017","title":"Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Spyre Therapeutics (SYRE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2663464017","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663464017?lang=en_us&edition=fundamental","pubTime":"2026-08-29 22:30","pubTimestamp":1788013830,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and Spyre Therapeutics (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","IE0009354923.USD","RVMD","IE0002141913.USD","LU0320765992.SGD","IE00BJT1NW94.SGD","IDNA","BBH","LU0109394709.USD","LU0128526141.USD","LU0029874061.USD","LABU","IE00B2B36J28.USD","HCSG","BK4581","BK4585","LFSC","XBI","IE00BJJMRZ35.SGD","BK4588","BK4137","CANC","XLV","IE00BFTCPJ56.SGD","BK4139","IE00B4R5TH58.HKD","SYRE","PTH","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663019703","title":"Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663019703","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663019703?lang=en_us&edition=fundamental","pubTime":"2026-08-29 08:52","pubTimestamp":1787964735,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Co ( ($JP:4502) ) just unveiled an announcement. Takeda has secured U.S. FDA approval for MIMRYLO (rusfertide), a first-in-cl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLVX","GDOC","PSCH","SYNB","PINK","MRNY","NVIB","BMED","LABU","LFSC","IEIH","TBXU","IBB","IYH","IDNA","BK4588","GNMX","MRNX","BK4585","RSPH","FRTY","MEDI","TECB","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016033","title":"Takeda receives FDA approval of NDA for Mimrylo","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016033","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663016033?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:00","pubTimestamp":1787958013,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced U.S. FDA approval of the New Drug Application for Mimrylo for the treatment of erythrocytosis in adults with polycythemia ve...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TECB","RSPH","TBXU","PSCH","IEIH","IDNA","BBP","SYNB","BMED","GDOC","NVIB","BK4007","LABU","MRNX","IYH","IBB","BK4585","LFSC","XLVX","BK4588","MEDI","FRTY","PINK","GNMX","TAK","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662009682","title":"Labcorp to Present at Morgan Stanley Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2662009682","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662009682?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:36","pubTimestamp":1787924191,"startTime":"0","endTime":"0","summary":"Labcorp Holdings ( ($LH) ) has issued an announcement. Labcorp Holdings Inc., a global leader in diagnostics and drug development laboratory servic...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/labcorp-to-present-at-morgan-stanley-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/labcorp-to-present-at-morgan-stanley-healthcare-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","FBT","XLV","LU0029874061.USD","BK4585","HCSG","BMED","XBI","BK4137","LABU","BK4581","LFSC","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662874134","title":"Roche receives FDA approval for companion diagnostic tests for Ziihera","url":"https://stock-news.laohu8.com/highlight/detail?id=2662874134","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662874134?lang=en_us&edition=fundamental","pubTime":"2026-08-27 03:00","pubTimestamp":1787770816,"startTime":"0","endTime":"0","summary":"Roche (RHHBY) announced that it has received FDA approval for expanded use of its PATHWAY HER2 and VENTANA HER2 Dual ISH DNA Probe Cocktail tests. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roche-receives-fda-approval-for-companion-diagnostic-tests-for-ziihera-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roche-receives-fda-approval-for-companion-diagnostic-tests-for-ziihera-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PINK","IEIH","MRNX","TECB","MEDI","GDOC","NVIB","RSPH","BMED","IDNA","FRTY","HRTS","GNMX","LABU","LFSC","PSCH","SYNB","RHHBY","MRNY","IBB","TBXU","BK4585","XLVX","BK4007","CANC","BK4588","BBP","IYH","03165"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662749365","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2662749365","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662749365?lang=en_us&edition=fundamental","pubTime":"2026-08-27 02:23","pubTimestamp":1787768612,"startTime":"0","endTime":"0","summary":"Electromed  Chief Executive Jim Cunniff plans to retire around April 2 after serving as president and CEO since 2023, it said late Tuesday, adding that the board plans to search for his successor.Shares declined 18%, with intraday trading volume rising to over 229,000 from a daily average of about 89,000.Greenland Mines  shares slumped 43% amid heavy trading after the company said it priced its public offering of 4 million shares for gross proceeds of about $20 million.Intraday trading volume catapulted to over 2.09 million from a daily average of about 174,000.Spyre Therapeutics  said late Tuesday its experimental rheumatoid arthritis drug SPY072 failed to meet the company's internal performance threshold needed to justify further stand-alone development, prompting a halt of its monotherapy RA program.Shares dropped 14% as intraday trading volume rose to over 1.96 million from a daily average of about 1.25 million.Price: 32.20, Change: -7.14, Percent Change: -18.15","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LFSC","BK4082","BK4139","GRML","SYRE","ELMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662797746","title":"Revolution Medicines prices Rasonque at $39,800 for 30-day supply","url":"https://stock-news.laohu8.com/highlight/detail?id=2662797746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662797746?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:45","pubTimestamp":1787766320,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) disclosed that following FDA approval of Rasonque for the treatment of adult patients with metastatic pancreatic adenoc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-prices-rasonque-at-39800-for-30-day-supply-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-prices-rasonque-at-39800-for-30-day-supply-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMED","IE00BFTCPJ56.SGD","TECB","PSCH","IE0009355771.USD","MEDI","IE00BJT1NW94.SGD","BK4585","MRNX","MRNY","IE0002141913.USD","BBP","GNMX","IE00B4R5TH58.HKD","GDOC","IEIH","NVIB","BBH","IE00B2B36J28.USD","CANC","LFSC","TBXU","IBB","LU0109394709.USD","LABU","LU0889565916.HKD","PTH","PINK","RVMD","BK4139","RSPH","IYH","FRTY","XLVX","BK4588","IDNA","SYNB","IE00BJJMRZ35.SGD","IE0009354923.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662074659","title":"Revolution Medicines announces FDA approval of Rasonque in adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2662074659","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662074659?lang=en_us&edition=fundamental","pubTime":"2026-08-27 01:05","pubTimestamp":1787763925,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) announced that the U.S. Food and Drug Administration has approved RASONQUE once-daily oral tablets, for the treatment o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-announces-fda-approval-of-rasonque-in-adults-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-announces-fda-approval-of-rasonque-in-adults-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B4R5TH58.HKD","BK4139","MEDI","LU0109394709.USD","BBH","CANC","PSCH","FRTY","IDNA","LU0889565916.HKD","RVMD","IE0009354923.USD","MRNX","BMED","IE00BJT1NW94.SGD","PINK","IYH","XLVX","BK4588","LABU","BBP","TECB","IE0002141913.USD","GNMX","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","TBXU","SYNB","NVIB","LU0320765992.SGD","PTH","IBB","LFSC","IE0009355771.USD","IEIH","BK4585","MRNY","RSPH","GDOC","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662474530","title":"Spyre Therapeutics falls -13.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662474530","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662474530?lang=en_us&edition=fundamental","pubTime":"2026-08-27 00:05","pubTimestamp":1787760324,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics (SYRE) is down -13.2%, or -$14.16 to $93.20. Published first on TheFly – the ultimate source for real-time, market-moving breaki...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/spyre-therapeutics-falls-13-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/spyre-therapeutics-falls-13-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","LFSC","LENZ","BK4539","SYRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662104247","title":"Spyre Therapeutics Down over 12%, on Pace for Largest Percent Decrease Since June 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2662104247","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662104247?lang=en_us&edition=fundamental","pubTime":"2026-08-26 22:35","pubTimestamp":1787754900,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics, Inc  is currently at $94.12, down $13.24 or 12.33%--Would be lowest close since July 16, 2026, when it closed at $94.12--On pace for largest percent decrease since June 17, 2024, when it fell 19.3%--Snaps a two day winning streak--Down 4.28% month-to-date; on pace for worst month since April 2025, when it fell 5.61%--Up 187.3% year-to-date--Down 68.6% from its all-time closing high of $299.75 on April 8, 2016--Up 449.12% from 52 weeks ago , when it closed at $17.14--Down 13.59% from its 52-week closing high of $108.92 on Aug. 19, 2026--Up 535.09% from its 52-week closing low of $14.82 on Sept. 16, 2025--Traded as low as $90.60; lowest intraday level since July 7, 2026, when it hit $86.60--Down 15.61% at today's intraday low; largest intraday percent decrease since June 24, 2026, when it fell as much as 15.87%All data as of 10:32:24 AM ETSource: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","SYRE","BK4139","BK4539","LENZ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662171137","title":"U.S. Stocks on the MOVE-Semtech, Donaldson, Meta","url":"https://stock-news.laohu8.com/highlight/detail?id=2662171137","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662171137?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:31","pubTimestamp":1787747476,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Semtech, Donaldson, MetaAugust 26 (Reuters)-U.S. stock index futures were little changed on Wednesday as investors stayed cautious ahead of AI bellwether Nvidia's earnings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL6N44N0NW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3S45H60.SGD","LU2764262908.HKD","TRUC","LU0823417737.USD","LU0979878070.USD","LU2249611893.SGD","LU2381873111.SGD","LU0211328371.USD","LU1201861165.SGD","LU1674673691.USD","LU2077746001.SGD","LU2111349929.HKD","PLTR","LU0342679015.USD","IE00BQXX3D17.EUR","LU0868494708.USD","LU1242518931.SGD","LU1043141396.HKD","LU1791710400.SGD","LU0742534661.SGD","LU2290526834.HKD","LU2168564065.EUR","LU0557290698.USD","BK4543","LU2463028550.USD","BK4554","IE00BWXC8680.SGD","LU0985489474.SGD","BK4139","IE00BDCRKT87.USD","LU0094547139.USD","LU2237443978.SGD","LU1280957306.USD","LU2236285917.USD","VGT","LU0054578231.USD","SOXQ","IE0009356076.USD","LU3102509885.SGD","LU2506952097.USD","LU2347655073.USD","LU2023250330.USD","IE00B5TLWC47.USD","LU2471134879.HKD","PLTW","LU2087621335.USD","LU2324357040.USD","LU0784384876.USD","SNPE","LU1244550494.USD","LU1066051498.USD","LU0114720955.EUR","LU1670756490.USD","IE00BFSS7M15.SGD","LU2279689827.SGD","LU2471134796.USD","LU0061474705.USD","TEK","LU2294711713.HKD","SG9999014542.SGD","IE00BFTCPJ56.SGD","LU1046421795.USD","LU0052756011.USD","LU0215105999.USD","LU2471134523.USD","LU0889566641.SGD","SG9999018857.SGD","LU1564329461.SGD","LU2506951792.HKD","LU2097344431.USD","LU1202635105.USD","LU1127390331.HKD","LU0642271901.SGD","NVDW","LU0823416689.USD","LU0661504455.SGD","LU1267930730.SGD","BK4588","LU2272731600.USD","LU2552382132.HKD","LU0965508806.USD","LU0006306889.USD","LU0788109477.HKD","LU0122379950.USD","LU2237443549.SGD","NOWL","LU0786609619.USD","IE00BDRTCR15.USD","DCI","LU0511384066.AUD","PLTY","LU0689472784.USD","LU2462157665.USD","LU0256863811.USD","LU0124676726.USD","LU1564329032.USD","IE00BZ1G4Q59.USD","LU2506951875.HKD","LU1979441026.SGD","LU0107464264.USD","LU0149725797.USD","CHPX","LU0965509010.AUD","LU1236620750.USD","LU2360032135.SGD","TYLG","LU0787776722.HKD","NVC","ROM","BK4527","LU1861215975.USD","LU1323610961.USD","NVD2.UK","LU2750360997.AUD","EFIV","TRUP","FBX","LU1861559042.SGD","LU0432979614.USD","LU0648000940.SGD","LU0057025933.USD","LU2112291526.USD","LU0316494557.USD","LU2404859741.USD","NVDB","CLSE","LU1868837300.USD","METD","LU1880398554.USD","LU2237957902.USD","LU1989764748.USD","LU2456880835.USD","LU2265009873.SGD","LU0175139822.USD","LU0689626769.HKD","LU1232071149.USD","LU2237443895.HKD","LU1242518857.USD","LU1066051811.HKD","LU1400636657.SGD","BK4507","LU0345774391.USD","LU1116320737.USD","IE00B775H168.HKD","LU1400636491.USD","SG9999000418.SGD","LU0203345920.USD","LU0477156953.USD","IGV","LU2404859667.USD","IE00BJJMRX11.SGD","LU2133065610.SGD","LU2286300806.USD","IE0003U64NQ7.SGD","LU0097036916.USD","HK0000819398.USD","IE0009G5SDU7.USD","LU2065170008.USD","BK4613","AIPI","GB00B4LPDJ14.GBP","NVDO","LU0353189680.USD","JGRO","LU0234570918.USD","LU1548497426.USD","SHOC","LU1815336760.USD","LU1084165304.USD","LU2430703251.USD","DIPS","SOXX","IE0004091025.USD","LU1035775433.USD","LU1941712264.USD","LU0203201768.USD","BK4533","FBYY","LU0012050646.USD","IE0004086264.USD","LU2361044949.HKD","LU2362541513.USD","LU0964807845.USD","LU2211815571.USD","LU0072461881.USD","LU0889565833.HKD","SPLTRmain","CLOD","LU2168564495.EUR","FAI","LU1623119135.USD","LU1941712348.USD","GAMR","LU2417539215.USD","NVD3.UK","LU1291159041.SGD","LU1988902786.USD","IE0034235295.USD","LU0957808578.USD","IE00BFXG0V08.USD","IE00BJLML261.HKD","LU2237443465.HKD","IE00BFSS8Q28.SGD","IE0005OL40V9.USD","LU2087625088.SGD","LU1645745479.HKD","LU2357125470.USD","LU0320765489.SGD","LU2361044865.SGD","PLTL","LU1712237335.SGD","LU0472753341.HKD","METU","XLK","LU0048573561.USD","LU0949170426.SGD","LU2063271972.USD","IE00B4JS1V06.HKD","LU0345769128.USD","LU0353189763.USD","LU1037948897.HKD","LU1629891620.HKD","LU2394011477.USD","LU2506952170.USD","LU1718418525.SGD","LU1244550577.SGD","XLC","LU0061475181.USD","LU1003077747.HKD","LU1983299246.USD","LU1267930227.SGD","LU0157215616.USD","LU1670711040.USD","LU0784385170.HKD","LU0130102774.USD","IE0001KFT4U8.USD","PLYY","LU0444971666.USD","LU0109391861.USD","LU1917777945.USD","PLTU","IE0009355771.USD","LU2362540622.SGD","IE0034235188.USD","LU0957791311.USD","LU0323240290.USD","LU0795875169.SGD","LU0251142724.SGD","LU0323591593.USD","BK4077","NVDY","IE00B1BXHZ80.USD","LU1074936037.SGD","LU2168564149.EUR","LU0882574055.USD","LU0289961442.SGD","IE00BJTD4V19.USD","LU1989772840.SGD","LU2095319765.USD","HK0000304797.USD","LU1153585028.USD","CHAT","LU1093756325.SGD","BK4567","LU0187121727.USD","SG9999014906.USD","BK4023","LU1061106388.HKD","LU2023251221.USD","LU2487616109.SGD","GXPC","LU0823414551.USD","LU0426417589.USD","NVYY","LU0323239441.USD","NVDL","LU1267930573.SGD","LU0082616367.USD","SPTE","SOXY","LU2430703178.SGD","LU0823434740.USD","HK0000320264.USD","LU1989772923.USD","LU1839511570.USD","LU0096364046.USD","GUNZ","LU2272731865.HKD","NOW","LU1983260115.SGD","LU1914381329.SGD","PLT","LU0251131958.USD","LU1815333072.USD","LFGY","BK4605","LU0965509101.SGD","LU2896262040.SGD","IE00B7KXQ091.USD","SG9999014559.SGD","LU1880398471.USD","LU0310800965.SGD","NVDS.UK","3NVD.UK","LFSC","LU1564329115.USD","LU0552385451.USD","LU2237443382.USD","PLTG","LU0109392836.USD","INTU","LU2413666426.HKD","NVDQ","LU1201861249.SGD","LU0708995401.HKD","SG9999018865.SGD","SG9999004303.SGD","LU0251132253.USD","LU2264538146.SGD","TTEQ","BK4503","IE00BKDWB100.SGD","LU1551013425.SGD","IE00B3SWFQ91.USD","SG9999014880.SGD","BK4612","LU2462591277.SGD","LU0795875086.SGD","IE00BMPRXQ63.HKD","BBWI","BK4534","IE00B19Z9P08.USD","LU2065171311.SGD","LU0162691827.USD","THMR","SG9999014567.USD","LU0950375773.USD","LU2931357623.SGD","LU0203347892.USD","LU0068578508.USD","PLTA","LU0048584097.USD","LU0029864427.USD","LU2462591350.SGD","LU1923622291.USD","LU2954938101.SGD","LU0130517989.USD","LU0494093205.USD","LU0683600562.USD","LU0210536198.USD","LU1670711123.USD","VT","HK0000914686.HKD","BK4504","IE000KEQY171.SGD","IE000Q6AESB8.SGD","LU0466842654.USD","LU1435385759.SGD","SGXZ23171101.USD","LU1935042991.SGD","LU2023250843.SGD","IE000ITXATA3.USD","LU1923623000.USD","LU2168564222.USD","BK4547","FCOM","BK4097","LU2347655156.SGD","LU0672654240.SGD","ZM","LU0354030438.USD","CMAG","LU0719512351.SGD","HK0000306701.USD","META","IE00BYQQ9H92.USD","SG9999002232.USD","BK4200","SYRE","IE00B1XK9C88.USD","LU0267386448.USD","SGXZ81514606.USD","LU0708994859.HKD","IE0000B7K699.USD","IE0002141913.USD","IE00B894F039.SGD","NVDX","USXF","IE00BN29S564.USD","LU2242650005.HKD","NVII","LU0079474960.USD","LU0308772762.SGD","LU1057294990.SGD","LU2413666699.HKD","LU0345768740.USD","LU2237957811.SGD","IE00BJJMRY28.SGD","IE00B19Z9Z06.USD","LU0053666078.USD","HK0000306685.HKD","LU0912757837.SGD","SG9999013999.USD","LU2092627202.USD","LU0234572021.USD","BK4532","IE00B19Z3B42.SGD","LU1429558221.USD","LU1699723380.USD","LU1023059063.AUD","BK4538","IE00BKVL7J92.USD","LU0210533765.USD","CRM","IE000WAW04H5.SGD","BK4107","BK4529","BK4549","LU0553294199.USD","LU0477156797.USD","LU2054465674.USD","LU2999663052.SGD","LU2756315318.SGD","LU1035773651.USD","LU0820561909.HKD","LU2125909916.SGD","FBY","LU0289960550.SGD","LU0143551892.USD","LU0792757196.USD","NVDS","IE00B19Z3581.USD","OGIG","IE00BHPRN162.USD","LU1261432733.SGD","LU1861220033.SGD","LU2746668461.USD","IE00BZ9MQY76.HKD","LU0070302665.USD","ILDR","IE00B19Z8X17.USD","LU1670710588.SGD","SOCL","LU0345770308.USD","LU1923622614.USD","LU0345768153.USD","LU1803068979.SGD","IE0034235303.USD","LU0314104364.USD","LU1935043023.USD","LU2720916845.USD","LU0823417653.USD","LU2491050071.SGD","LU2602419157.SGD","LU1069347547.HKD","LU1697837992.HKD","LU0640476718.USD","LU0724617625.USD","LU1721428933.USD","METQ","BK4592","HK0000914660.USD","LU2322448791.USD","LU1366333091.USD","LTL","IE000BZT7R73.USD","LU0130103400.USD","LU0011850046.USD","LU1791710582.SGD","2NVD.UK","BK4587","LU2242649171.HKD","LU1935043536.SGD","SNVD.UK","IETC","LU1821325948.USD","LU2420271590.USD","LU2860962120.EUR","SG9999001077.SGD","SG9999015986.USD","LU0861579265.USD","LU1989771016.USD","LU2097829019.USD","LU2326559502.SGD","LU0061474960.USD","LU2491049909.HKD","SG9999001424.SGD","LU0994945656.USD","ESLG","BK4607","LU2089985449.USD","LU2505996681.GBP","LU2065169927.USD","IE00B4R5TH58.HKD","BK4162","LU1119994496.HKD","IE00BK4W5L77.USD","IE000W1ABFV2.USD","LU2244417387.USD","BK4608","SMTG","LU2213496289.HKD","AIFD","XDAT","BK4524","LU1267930813.SGD","BHVN","LU0128525929.USD","LU2191332357.HKD","LU0158827781.USD","LU0738911758.USD","LU2317271919.USD","LU1674673428.USD","IE00B775SV38.USD","LU1670627923.USD","LU2089283258.USD","LU1823568750.SGD","NVDD","IE00B2B36J28.USD","LU0784383803.USD","IE00B19Z9505.USD","LU0823434583.USD","LU2083900584.USD","SG9999015952.SGD","BSX","LU0868494617.USD","IE00BQXX3C00.GBP","LU0198837287.USD","LU0476273544.USD","LU1992135472.HKD","LU1116320901.HKD","LU2471134952.CNY","BK4141","TTXU","LU0823421416.USD","LU1037948541.HKD","BK4551","IE000YTNTUN2.SGD","SGXZ99366536.SGD","BK4581","PTIR","ADBG","LU1145028129.USD","LU0426412945.USD","LU0138981039.USD","LU0265550359.USD","LU1934455863.HKD","LU0128525689.USD","TRFK","LU2065171402.SGD","LU1235294995.USD","LU1868836914.USD","NVDA","LU1861127337.USD","LU2750360641.GBP","BK4528","LU0170899867.USD","LU0726765562.USD","LU2210149790.SGD","IE00BQXX3F31.USD","LU0965509283.SGD","SG9999015978.USD","LU0133085943.USD","LU1868836591.USD","LU0077335932.USD","LU2210150020.SGD","LU1868837136.USD","LU1059921491.USD","SG9999001176.SGD","LU1244550221.USD","IE0004445015.USD","LU1670628061.USD","LU2491050154.USD","LU1935042215.USD","LU1989764664.SGD","LU0265550946.USD","USD","LU0942090050.USD","LU0266013472.USD","LU1301847155.USD","LU1069344957.HKD","LU0205194284.USD","LU2764263203.CNY","BK4585","LU1564329628.SGD","BK4535","LU0203202063.USD","LU0345774631.USD","LU0949170772.SGD","LU1267930490.SGD","LU0820561818.USD","ARTY","LU1691799644.USD","IE00BJTD4N35.SGD","LU2357305700.SGD","PLTD","SHLD","GB00BDT5M118.USD","METW","NVDG","SMTC","LU2272731782.SGD","IE00B5949003.HKD","LU0417517546.SGD","LU1496350502.SGD","LU1951198990.SGD","LU1951200564.SGD","LU2764263039.SGD","LU2756315664.SGD","LU0225283273.USD","LU0310800379.SGD","IXN","SG9999017495.SGD","LU0395794307.EUR","LU0276348264.USD","LU2505996509.AUD","LU1720051017.SGD","LU2100268510.USD","LU2047632596.USD","NULC","LU0174119429.USD","LU1066053197.SGD","LU2023250504.SGD","SG9999015945.SGD","LU0690374961.EUR","PLOO","LU1861558580.USD","LU1974910355.USD","LU2125909759.SGD","LU0310799852.SGD","LU0238689110.USD","LU2746668974.SGD","LU2552382215.SGD","ESUM","LU2125909593.SGD","LU1804176565.USD","LU1852331112.SGD","LU1043141123.HKD","LU0444973449.USD","LU2125154935.USD","LU2148611432.USD","LU2089284900.SGD","SG9999014898.SGD","LU1868836757.USD","LU0127658192.USD","HK0000320223.HKD","LU0205193047.USD","LU1934455277.USD","LU0820562030.AUD","NVDU","SG9999001176.USD","LU0256863902.USD","AGOX","LU1633808545.USD","LU0345769631.USD","LU1720051108.HKD","LU1814569148.SGD","LU0289739343.SGD","LU0158827948.USD","LU2361045086.USD","FBL","METV","LU1316542783.SGD","SGXZ31699556.SGD","LU1551013342.USD","BK4566","IE0004445239.USD","LU2360106780.USD","LU1400636574.HKD","LU0943347566.SGD","LU1732799900.SGD","HK0000304805.HKD","LU0072462426.USD","LU0784385840.USD","LU1366192091.USD","IE00B4YYXB79.USD","SMETAmain","SNVDAmain","LU2322448957.HKD","SMH","SGXZ57979304.SGD","LU0878866978.SGD","LU2592432038.USD","LU0354030511.USD","PLTZ","LU2092937148.SGD","LU0211331839.USD","LU0390134368.USD","LU2125154778.USD","LU0433182093.SGD","LU0080751232.USD","CRMG","LU1144417596.USD","ABFL","BK4505","IE000MB6IJN5.SGD","07388","LU2237443622.USD","LU0690374615.EUR","LU0545039389.USD","LU1496350171.SGD","IE00BJT1NW94.SGD","LU1935042488.USD","LU0823421333.USD","BK4614","LU2461242641.AUD","LU2403377893.USD","SMHX","LU2271345857.HKD","LU1236620834.HKD","LU2362541273.HKD","LU2552382058.USD","LU0211327993.USD","IE00BJJMRZ35.SGD","IE00BMPRXR70.SGD","BK4561","METG","LU1093756168.USD","07788","LU1732800096.USD","LU2506951958.HKD","LU2430703095.HKD","IE00BKPKM429.USD","LU0081259029.USD","FTEC","IE0002270589.USD","ADBE","IE00BD6J9T35.USD","BK4550","WISE","BK4579","PLTI","SGXZ80539844.SGD","SG9999002224.SGD","LU2097344357.USD","LU0106261612.USD","LU0069063385.USD","IE00BK4W5M84.HKD","ADBU","LU0096362180.USD","NOWX","IE000F7OJYX1.SGD","LU2637965513.SGD","IE00B19Z8W00.USD","IE00BMPRXN33.USD","LU1642822529.SGD","LU2433249047.HKD","LU2168563687.JPY","NVIW.SI","LU0345770993.USD","CNEQ","SG9999015358.SGD","LU2237438978.USD","BK4525","LU2458330243.SGD","LU0106261372.USD","LU2247934214.USD","IE00BYXW3230.USD","LU0154236417.USD","LU0985320562.USD","LU0648001328.SGD","LU0208291251.USD","LU1992135399.USD","LU0320765059.SGD","LU0347712357.USD","BK4161","BK4598","LU0210528500.USD","LU0980610538.SGD","LU2458330169.SGD","SG9999015341.SGD","FDTX","IE00B3M56506.USD","HK0000532082.HKD","LU1064131342.USD","LU0130518102.USD","LU1121112475.USD","BK4082","LU1571399168.USD","LU0348723411.USD","LU1778281490.HKD","LU2250418816.HKD","ANV","LU0882574139.USD","LU2360107168.USD","LU2473716301.USD","IE000SO60NU8.SGD","IE00BZ199S13.USD","LU2028103732.USD","LU1489326972.SGD","LU0070217475.USD","IE00B7SZLL34.SGD","LU1066051225.USD","SGXZ51526630.SGD","VOX","NVD","LU2452424414.USD","LU0056508442.USD","LU0528227936.USD","LU1934455194.USD","LU2108987350.USD","LU2125909247.SGD","BK4548","GB00B4QBRK32.GBP","LU2106854487.HKD","LU2543165471.USD","RSPC","LU0274383776.USD","LU1670710661.SGD","SG9999014575.USD","SG9999014914.USD","EYES","LU0823414478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662164967","title":"Spyre Therapeutics (SYRE) Gets a Buy from LifeSci Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2662164967","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662164967?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:55","pubTimestamp":1787745337,"startTime":"0","endTime":"0","summary":"In a report released today, Sam Slutsky from LifeSci Capital maintained a Buy rating on Spyre Therapeutics, with a price target of $116.00. Slutsky...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/spyre-therapeutics-syre-gets-a-buy-from-lifesci-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/spyre-therapeutics-syre-gets-a-buy-from-lifesci-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYRE","LFSC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662239718","title":"Analysts Offer Insights on Healthcare Companies: Solventum Corporation (SOLV), Argenx Se (ARGX) and Spyre Therapeutics (SYRE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662239718","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662239718?lang=en_us&edition=fundamental","pubTime":"2026-08-26 18:50","pubTimestamp":1787741417,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Solventum Corporation (SOLV), Argenx Se (ARGX) and S...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-solventum-corporation-solv-argenx-se-argx-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-solventum-corporation-solv-argenx-se-argx-and-spyre-therapeutics-syre-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2324357040.USD","LU0109394709.USD","BK4139","IE00B2B36J28.USD","SOLV","BK4585","IE00B4R5TH58.HKD","LU0320765992.SGD","IE0034235188.USD","BK4581","BK4198","BK4588","IE0002141913.USD","TBXU","LU0029874061.USD","HCSG","LABU","BK4505","LFSC","IBB","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU0823416689.USD","BK4137","FMED","ARGX","LU1983260115.SGD","LU0128526141.USD","IE0009355771.USD","XLV","XBI","LU0889565916.HKD","IE00BJJMRZ35.SGD","SYRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662979105","title":"Spyre Therapeutics Reports Phase 2 Skyway RA Data for Spy072 Shows Statistically Significant Benefit vs Placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2662979105","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662979105?lang=en_us&edition=fundamental","pubTime":"2026-08-26 17:30","pubTimestamp":1787736639,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics reports Phase 2 SKYWAY RA data for SPY072 shows statistically significant benefit vs placeboSpyre Therapeutics reported topline Phase 2 SKYWAY rheumatoid arthritis sub-study results","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL2xmQmj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SYRE","BK4139","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662799910","title":"Spyre Therapeutics Shares Down 12.4% Premarket After Co's Experimental Drug Fails to Meet Threshold for Monotherapy Development in Rheumatoid Arthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2662799910","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662799910?lang=en_us&edition=fundamental","pubTime":"2026-08-26 16:57","pubTimestamp":1787734667,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL4N44N0KB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SYRE","BK4139","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662760351","title":"Circio and Full Circles join forces on non-viral in vivo cell therapy platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2662760351","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662760351?lang=en_us&edition=fundamental","pubTime":"2026-08-26 13:43","pubTimestamp":1787723005,"startTime":"0","endTime":"0","summary":"Targovax ASA ( ($GB:0RIS) ) just unveiled an announcement. Circio Holding ASA and Full Circles Therapeutics have entered a research collaboration t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/circio-and-full-circles-join-forces-on-non-viral-in-vivo-cell-therapy-platform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/circio-and-full-circles-join-forces-on-non-viral-in-vivo-cell-therapy-platform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FBT","BK4588","BK4585","SYNB","IBB","GNOM","TBXU","IBBQ","CNCR","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662762356","title":"Spyre Therapeutics Inc : Btig Cuts Target Price to $121 from $132","url":"https://stock-news.laohu8.com/highlight/detail?id=2662762356","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662762356?lang=en_us&edition=fundamental","pubTime":"2026-08-26 12:34","pubTimestamp":1787718880,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N05M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SYRE","BK4139","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662768622","title":"Stocks to Watch: Intuit, Spyre Therapeutics, Zoom Communications, nCino","url":"https://stock-news.laohu8.com/highlight/detail?id=2662768622","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662768622?lang=en_us&edition=fundamental","pubTime":"2026-08-26 07:05","pubTimestamp":1787699100,"startTime":"0","endTime":"0","summary":"Intuit projected that sales growth would slow in the year ahead, weighed down by expected declines in the company's desktop business. The company may also accept short-term trade-offs in its business as it looks to boost TurboTax customers, its CFO told The Wall Street Journal. Shares fell 9.8% to $322.57 in after-hours trading on Tuesday.Spyre Therapeutics said it will not prioritize developing one of its drug candidates as a monotherapy for rheumatoid arthritis after results from a trial missed its internal targets. The stock slid 11% to $95.09 after the bell.Zoom Communications issued guidance for third-quarter adjusted earnings per share that missed Wall Street expectations. Shares were down 3.9% at $97.00.NCino projected third-quarter revenue in a range with a midpoint below analyst expectations. The stock was down 5.6% at $19.65.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109392836.USD","LU0738911758.USD","LU1280957306.USD","IE00B19Z9505.USD","LU1366333091.USD","LU0157215616.USD","ZM","LU1037948897.HKD","LU1823568750.SGD","LU0097036916.USD","LU0158827948.USD","BK4548","LU0889565833.HKD","BK4534","NCNO","SYRE","LU1934455277.USD","LU1236620750.USD","BK4525","LU2089284900.SGD","LU2065171402.SGD","LU0061474960.USD","LU2023251221.USD","BK4532","BK4554","LU0426412945.USD","GB00BDT5M118.USD","BK4139","BK4533","LU0661504455.SGD","LU0965509283.SGD","LU2095319765.USD","SG9999002224.SGD","LU1674673428.USD","LU1815333072.USD","LU2065171311.SGD","LU0289739343.SGD","IE00B5949003.HKD","LU1674673691.USD","IE0009356076.USD","BK4505","BK4613","BK4567","LU1121112475.USD","BK4588","LU0823434740.USD","LU2065169927.USD","LU0949170772.SGD","LU0289961442.SGD","LU1043141123.HKD","LU0823434583.USD","BK4023","LU2265009873.SGD","IE00BQXX3D17.EUR","LU1236620834.HKD","LU0965509010.AUD","LU0861579265.USD","LU0965508806.USD","IE00B19Z8X17.USD","LU0011850046.USD","LU1037948541.HKD","IE00BQXX3C00.GBP","LU1235294995.USD","LU1861559042.SGD","LU0266013472.USD","LU0689626769.HKD","LU1804176565.USD","LU1861558580.USD","LU1046421795.USD","LU1934455194.USD","LU0511384066.AUD","LU2063271972.USD","INTU","SG9999002232.USD","LU0957791311.USD","BK4585","IE00B19Z8W00.USD","LU0965509101.SGD","LU0342679015.USD","BK4608","LU1043141396.HKD","LU2210149790.SGD","IE00BQXX3F31.USD","BK4581","LU0082616367.USD","LU0426417589.USD","SG9999001424.SGD","LU0124676726.USD","LU0719512351.SGD","BK4535","BK4551","LU2210150020.SGD","LU0345774631.USD","BK4528","LU2089283258.USD","LU1778281490.HKD","LFSC","LU2065170008.USD","LU0640476718.USD","LU1934455863.HKD","LU1803068979.SGD","LU0994945656.USD","LU0345774391.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}